Company Search:
Advanced Search
Sponsored Links
Quidel Corporation Company Snapshot
Quidel Corporation operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Quidel with three other pharmaceutical manufacturers in North America: FibroGen Inc (2015 sales of $180.83 million ), Lifevantage Corp ($190.34 million of which 100% was Protandim), and Meridian Bioscience, Inc. ($194.83 million of which 75% was US Diagnostics).

Sales Analysis. Quidel reported sales of $196.13 million for the year ending December of 2015. This represents an increase of 7.4% versus 2014, when the company's sales were $182.62 million. This was the third consecutive year of growth at Quidel.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Quidel Corporation
  Stock Performance Chart for Quidel Corporation
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 21.30
(Figures in U.S. Dollars)
1 Week 2.3%   13 Weeks -6.2%  
4 Weeks 9.0%   52 Weeks 18.5%  
Quidel Corporation Key Data:
  Ticker: QDEL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 196,129,000
(Year Ending Jan 2016).
Employees: 624
  Currency: U.S. Dollars Market Cap: 689,956,608
  Fiscal Yr Ends: December Shares Outstanding: 32,392,329
  Share Type: Common Closely Held Shares: 5,838,866
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.